Measurement of malaria vaccine efficacy in phase III trials: Report of a WHO consultation

Vaccine

Volumn 25, Issue 28, 2007, Pages 5115-5123

  Moorthy, Vasee ^a   Reed, Zarifah ^b   Smith, Peter G ^c  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b Initiative for Vaccine Research   (Switzerland)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Efficacy trials; Malaria vaccines; Phase III trials

Indexed keywords

ANTIMALARIAL AGENT; MALARIA VACCINE; PNEUMOCOCCUS VACCINE;

CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; MALARIA; PARASITEMIA; PATHOGENESIS; PLASMODIUM FALCIPARUM; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; WORLD HEALTH ORGANIZATION;

CLINICAL TRIALS, PHASE III; HUMANS; MALARIA; MALARIA VACCINES; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 34249107535     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.085     Document Type: Conference Paper

References (26)

1. Smith T., Schellenberg J.A., and Hayes R. Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med 13 November (22) (1994) 2345-2358
2. Snow R.W., Craig M., Deichmann U., and Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ 77 8 (1999) 624-640
3. Breman J.G. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am J Trop Med Hyg 64 January-February (1-2 Suppl.) (2001) 1-11
4. Guerin P.J., Olliaro P., Nosten F., Druilhe P., Laxminarayan R., Binka F., et al. Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis 2 9 (2002) 564-573
5. Hill A.V. Pre-erythrocytic malaria vaccines: towards greater efficacy. Nat Rev Immunol 6 January (1) (2006) 21-32
6. Maire N., Aponte J.J., Ross A., Thompson R., Alonso P., Utzinger J., et al. Modeling a field trial of the RTS, S/AS02A malaria vaccine. Am J Trop Med Hyg 75 August (2 Suppl.) (2006) 104-110
7. Good M.F. Towards a blood-stage vaccine for malaria: are we following all the leads?. Nat Rev Immunol 1 November (2) (2001) 117-125
8. Richie T.L., and Saul A. Progress and challenges for malaria vaccines. Nature 415 February (6872) (2002) 694-701
9. Malkin E.M., Durbin A.P., Diemert D.J., Sattabongkot J., Wu Y., Miura K., et al. Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. Vaccine 23 May (24) (2005) 3131-3138
10. Ballou W.R., Arevalo-Herrera M., Carucci D., Richie T.L., Corradin G., Diggs C., et al. Update on the clinical development of candidate malaria vaccines. Am J Trop Med Hyg 71 August (2 Suppl.) (2004) 239-247
11. Moorthy V.S., Good M.F., and Hill A.V. Malaria vaccine developments. Lancet 363 January (9403) (2004) 150-156
12. Stoute J.A., Slaoui M., Heppner D.G., Momin P., Kester K.E., Desmons P., et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N Engl J Med 336 2 (1997) 86-91 [see comments]
13. Stoute J.A., Kester K.E., Krzych U., Wellde B.T., Hall T., White K., et al. Long-term efficacy and immune responses following immunization with the RTS, S malaria vaccine. J Infect Dis 178 4 (1998) 1139-1144
14. Kester K.E., McKinney D.A., Tornieporth N., Ockenhouse C.F., Heppner D.G., Hall T., et al. Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. J Infect Dis 183 4 (2001) 640-647
15. Bojang K.A., Milligan P.J., Pinder M., Vigneron L., Alloueche A., Kester K.E., et al. Efficacy of RTS, S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358 December (9297) (2001) 1927-1934
16. Alonso P.L., Sacarlal J., Aponte J.J., Leach A., Macete E., Milman J., et al. Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364 October (9443) (2004) 1411-1420
17. Alonso P.L., Sacarlal J., Aponte J.J., Leach A., Macete E., Aide P., et al. Duration of protection with RTS, S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 366 December (9502) (2005) 2012-2018
18. Cutts F.T., Zaman S.M., Enwere G., Jaffar S., Levine O.S., Okoko J.B., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365 March-April (9465) (2005) 1139-1146
19. WHO. Guidelines for the evaluation of Plasmodium falciparum vaccines in populations exposed to natural infection 1997, available online at www.who.int/tdr/publications/publications/malaria_vaccine.htm.
20. Taylor T., Olola C., Valim C., Agbenyega T., Kremsner P., Krishna S., et al. Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network. Trans R Soc Trop Med Hyg 100 July (7) (2006) 615-622
21. Marsh K., Forster D., Waruiru C., Mwangi I., Winstanley M., Marsh V., et al. Indicators of life-threatening malaria in African children. N Engl J Med 332 May (21) (1995) 1399-1404
22. Schellenberg D., Menendez C., Kahigwa E., Font F., Galindo C., Acosta C., et al. African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death. Am J Trop Med Hyg 61 September (3) (1999) 431-438
23. Newton C.R., Valim C., Krishna S., Wypij D., Olola C., Agbenyega T., et al. The prognostic value of measures of acid/base balance in pediatric falciparum malaria, compared with other clinical and laboratory parameters. Clin Infect Dis 41 October (7) (2005) 948-957
24. WHO. Severe malaria. Trans R Soc Trop Med Hyg 94 Suppl. 1 (2000)
25. Newton C.R., Hien T.T., and White N. Cerebral malaria. J Neurol Neurosurg Psychiatry 69 October (4) (2000) 433-441
26. Henry M.C., Assi S.B., Rogier C., Dossou-Yovo J., Chandre F., Guillet P., et al. Protective efficacy of lambda-cyhalothrin treated nets in Anopheles gambiae pyrethroid resistance areas of Cote d'Ivoire. Am J Trop Med Hyg 73 November (5) (2005) 859-864